miR-3960 from Mesenchymal Stem Cell-Derived Extracellular Vesicles Inactivates SDC1/Wnt/β-Catenin Axis to Relieve Chondrocyte Injury in Osteoarthritis by Targeting PHLDA2
Osteoarthritis (OA) is a serious disease of the articular cartilage characterized by excessive inflammation. Lately, mesenchymal stem cell- (MSC-) derived extracellular vesicles (EVs) have been proposed as a novel strategy for the treatment of OA. We aimed to investigate the effects of EV-encapsulat...
Saved in:
Main Authors: | Peng Ye, Zhanhu Mi, Daihao Wei, Pengcheng Gao, Mei Ma, Haibo Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2022/9455152 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bergapten alleviates senescence of chondrocytes in osteoarthritis
by: YE Yuanlan, et al.
Published: (2025-02-01) -
Cell-free osteoarthritis treatment with dual-engineered chondrocyte-targeted extracellular vesicles derived from mechanical loading primed mesenchymal stem cells
by: Peng Wang, et al.
Published: (2025-02-01) -
Targeting Chondrocyte Hypertrophy as Strategies for the Treatment of Osteoarthritis
by: Da-Long Dong, et al.
Published: (2025-01-01) -
Skatole Alleviates Osteoarthritis by Reprogramming Macrophage Polarization and Protecting Chondrocytes
by: Weiyun Wang, et al.
Published: (2025-01-01) -
Fasting activates optineurin-mediated mitophagy in chondrocytes to protect against osteoarthritis
by: Min-Na Zhang, et al.
Published: (2025-01-01)